Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Anticipated CAGR of the Cancer Diagnostics Market, and What Factors Will Drive It?

The market size for cancer diagnostics has seen substantial growth in the past years. The forecast shows a rise from $23.24 billion in 2024 to $25.5 billion in 2025, equating to a compound annual growth rate (CAGR) of 9.7%. The growth during the historical period can be attributed to a rise in cancer cases, cancer screening initiatives, personalized healthcare, and heightened public awareness.

In the coming years, a swift expansion is foreseen for the cancer diagnostics market, with it expected to reach $40.07 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.0%. Key factors driving this growth during the forecast period include a surge in emerging markets, supportive regulatory frameworks, advancements in artificial intelligence (AI) and machine learning, and a focus on early detection and intervention. The anticipated trends during this period encompass liquid biopsies, utilization of multi-omics methods, point-of-care testing, and campaigns for screening and early intervention.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2570&type=smp

What Are the Core Growth Drivers Propelling the Cancer Diagnostics Market Forward?

The cancer diagnostics market is significantly propelled by the high incidence rate of diverse kinds of cancers. This is attributed to the rising occurrences of various cancer types, prompting more individuals to choose diagnosis and treatment. Furthermore, cancer was identified by the World Health Organization (WHO) as the second most common cause of death globally. Meanwhile, the National Cancer Institute (NCI) projects that the annual new cancer cases will escalate to 23.6 million by the year 2030.

What Segment Types Define the Cancer Diagnostics Market Structure?

The cancer diagnosticsmarket covered in this report is segmented –

1) By Products: Companion Diagnostics, Molecular Diagnostics

2) By Method: Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging

3) By Application: Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma, Other Applications

4) By End-User: Cancer Research Institutes, Diagnostic Laboratories, Hospitals, Other End Users

Subsegments:

1) By Companion Diagnostics: Biomarker-Based Companion Diagnostics, Genetic Testing-Based Companion Diagnostics, Immunohistochemistry-Based Companion Diagnostics, PCR-Based Companion Diagnostics, Other Companion Diagnostics,

2) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Diagnostics, Next-Generation Sequencing (NGS) Diagnostics, In Situ Hybridization Diagnostics, Microarray-Based Diagnostics, DNA Or RNA Extraction Kits, Other Molecular Diagnostics

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2570&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Cancer Diagnostics Market?

North America was the largest region in the cancer diagnostics market in 2024. Asia-Pacific was the second-largest region in the global cancer diagnostics market. The regions covered in the cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Which Emerging Trends that Are Influencing theCancer Diagnostics Industry Evolution?

The rise of AI-assisted cancer detection systems is a burgeoning trend in the cancer diagnostics market. AI significantly enhances the precision of image detection in diagnostic methods such as detecting breast and lung cancer, by identifying the cancers in their initial stages. AI also minimizes the occurrence of false positives in lung cancer screenings, thereby, heightening the accuracy of lung cancer detection. For example, a trustworthy solution composed of cancer-spotting algorithms for independent assessment of lymph node biopsies was built by the collective efforts of researchers at the Naval Medical Center San Diego and Google’s AI research division Google AI. This AI intervention amplified the detection precision of metastatic breast cancer to 99%.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cancer-diagnostics-global-market-report

What Is the Definition of the Cancer Diagnostics Market?

Cancer diagnostics refers to the processes, tests, and technologies used to identify the presence of cancer in individuals. This field encompasses a range of methodologies designed to detect, stage, and characterize cancer, allowing for timely and effective treatment.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2570

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model